Nystatin and Triamcinolone Acetonide ointment is indicated for the treatment of cutaneous candidiasis
The product will be manufactured at Lupin’s facility in Pithampur, India
First of three Amneal biosimilars expected for U.S. approval and launch in 2022
Sevelamer Hydrochloride tablets, 800 mg is a generic equivalent of Renagel tablets, 800 mg
To be marketed by Strides Pharma Inc. in the US market
The entire integration and transition of the brands is expected to be completed by March 2022
Key takeaways of Q3FY22 quarter & conference call highlights
The Vasostrict brand market had U.S. sales of approximately US $ 878.5 million MAT for the most recent twelve months ending in December 2021 according to IQVIA Health
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
It has a total of 50 ANDA approvals from USFDA
Subscribe To Our Newsletter & Stay Updated
